Syndax Pharmaceuticals, Inc. (SNDX)
20.41
-0.21
(-1.02%)
USD |
NASDAQ |
Dec 11, 16:00
20.40
-0.01
(-0.05%)
After-Hours: 20:00
Syndax Pharmaceuticals Research and Development Expense (TTM): 245.67M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Arcutis Biotherapeutics, Inc. | 71.08M |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Verastem, Inc. | 103.74M |
| Puma Biotechnology, Inc. | 60.40M |
| Krystal Biotech, Inc. | 55.37M |